Active Cancer Biomarkers Grants

PI Name Organization - Company Titlesort descending Major Program / Research Group FOA
Zarrinpar, Amir University Of California, San Diego Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer RFA-CA-20-054: Collaborative Approaches to Engineer Biology for Cancer Applications
Moormann, Ann M Univ Of Massachusetts Med Sch Worcester Enhancing racial and ethnic diversity inCOVID-19 research participation through storytelling (COVIDstory) COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Shi, Honglan Missouri University Of Science & Technology Establishing Biological Significance of Pteridine Metabolites in Progressive Breast Cancer PAR-18-021: NCI Small Grants Program for Cancer Research
Lin, Daniel W. Fred Hutchinson Cancer Center Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance PAR-18-310: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed)
Goel, Ajay Beckman Research Institute/City Of Hope Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Wu, Yun State University Of New York At Buffalo Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Wu, Yun State University Of New York At Buffalo Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Innovative Technology Development for Cancer Research RFA-CA-18-002: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Zhu, Yazhen University Of California Los Angeles Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Godwin, Andrew K. University Of Kansas Medical Center Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
Meltzer, Stephen J Johns Hopkins University Facile screening for esophageal cancer in LMICs RFA-CA-15-024: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3)
Balu, Mihaela University Of California-Irvine Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma PAR-20-155: Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
Chung, Fung-Lung Georgetown University gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention PAR-15-307: Translational Studies on Adducts for Cancer Risk Identification and Prevention
Schnaar, Ronald L Johns Hopkins University Ganglioside interactome toolkit RFA-RM-18-036: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions
Elenitoba-Johnson, Kojo S. J. University Of Pennsylvania Genomic biomarkers of splenic lymphoma PA-19-056: Research Project Grant
Abbott, Karen L. Florida International University Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers Alliance of Glycobiologists for Cancer Research PAR-17-206: Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories

Pages